The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADICET BIO INC | COM | 007002108 | 10,551 | 1,025,405 | SH | SOLE | 1,025,405 | 0 | 0 | ||
| AFFIMED N V | COM | N01045108 | 27,000 | 3,176,418 | SH | SOLE | 3,176,418 | 0 | 0 | ||
| ALPHA TEKNOVA INC | COM | 02080L102 | 1,780 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 2,680 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| BCTG ACQUISITION CORP | COM | 05492W103 | 2,048 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
| CAREMAX INC | *W EXP 06/08/202 | 14171W111 | 217 | 45,960 | SH | SOLE | 45,960 | 0 | 0 | ||
| CAREMAX INC | COM CL A | 14171W103 | 2,748 | 213,036 | SH | SOLE | 213,036 | 0 | 0 | ||
| CASI PHARMACEUTICALS INC | COM | 14757U109 | 15,999 | 10,321,956 | SH | SOLE | 10,321,956 | 0 | 0 | ||
| CELLECTAR BIOSCIENCES INC | COM PAR | 15117F500 | 4,656 | 3,913,000 | SH | SOLE | 3,913,000 | 0 | 0 | ||
| CONFORMIS INC | COM | 20717E101 | 14,656 | 12,744,030 | SH | SOLE | 12,744,030 | 0 | 0 | ||
| CONSONANCE HFW ACQUISITION C | UNIT 99/99/9999 | G2445M129 | 10,391 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 14,213 | 388,222 | SH | SOLE | 388,222 | 0 | 0 | ||
| GAMIDA CELL LTD | SHS | M47364100 | 18,323 | 2,858,558 | SH | SOLE | 2,858,558 | 0 | 0 | ||
| GLOBUS MED INC | CL A | 379577208 | 84,118 | 1,084,979 | SH | SOLE | 1,084,979 | 0 | 0 | ||
| HELIX ACQUISITION CORP | COM CL A | G4444C102 | 1,552 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| INFINITY PHARMACEUTICALS INC | COM | 45665G303 | 11,263 | 3,766,817 | SH | SOLE | 3,766,817 | 0 | 0 | ||
| JIYA ACQUISITION CORP | COM CL A | 47760M102 | 2,982 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| KEROS THERAPEUTICS INC | COM | 492327101 | 37,708 | 887,885 | SH | SOLE | 887,885 | 0 | 0 | ||
| LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 67,630 | 1,647,497 | SH | SOLE | 1,647,497 | 0 | 0 | ||
| MEDICUS SCIENCES ACQUISITION | *W EXP 02/12/202 | G5960S124 | 34 | 33,331 | SH | SOLE | 33,331 | 0 | 0 | ||
| MEDICUS SCIENCES ACQUISITION | CL A SHS | G5960S108 | 2,895 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| NKARTA INC | COM | 65487U108 | 13,940 | 439,876 | SH | SOLE | 439,876 | 0 | 0 | ||
| PANACEA ACQUISITION CORP II | CL A SHS | G6882C106 | 2,002 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 154,696 | 3,446,874 | SH | SOLE | 3,446,874 | 0 | 0 | ||
| RESEARCH ALLIANCE CORP II | COM CL A | 760873109 | 3,032 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 31,819 | 409,301 | SH | SOLE | 409,301 | 0 | 0 | ||
| SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | 5,779 | 222,222 | SH | SOLE | 222,222 | 0 | 0 | ||
| SIO GENE THERAPIES INC | COMMON | 829399104 | 8,108 | 2,969,987 | SH | SOLE | 2,969,987 | 0 | 0 | ||
| SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 98,838 | 1,199,339 | SH | SOLE | 1,199,339 | 0 | 0 | ||
| TANDEM DIABETES CARE INC | COM NEW | 875372203 | 95,377 | 979,226 | SH | SOLE | 979,226 | 0 | 0 | ||
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 28,542 | 159,087 | SH | SOLE | 159,087 | 0 | 0 | ||
| VERASTEM INC | COM | 92337C104 | 55,352 | 13,600,014 | SH | SOLE | 13,600,014 | 0 | 0 | ||